SEC Form 4 · accession 0001140361-16-049631
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Tiago Girao
Officer — VP & Chief Financial Officer
Period of report
Jan 28, 2016
Accepted (ET)
Feb 1, 2016 · 7:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 28, 2016 | A | 35,250 | $0.00 | A | 123,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock issued under the Company's 2015 Executive Management Incentive Compensation Plan and vested based upon level of achievement of certain metrics related to clinical trial enrollment and the Company's financial position for the performance period of May 26, 2015 to December 31, 2015. All shares were issued pursuant to the Company's 2014 Equity Incentive Plan.
- F2Includes 3,000 shares of Common Stock purchased through the 2011 Employee Stock Purchase Plan on November 30, 2015.